Cedars-Sinai is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Cedars-Sinai has participated in 33 clinical trials with 17 currently active.
Therapeutic areas: Non-Small-Cell Lung Cancer, Mitral Valve Regurgitation (Degenerative or Functional), Locally Advanced Solid Tumors.
Sponsors: BioAtla, Inc., Edwards Lifesciences, NeuPharma, Inc..
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai has 33 clinical trials on record, with 17 currently active. Their work covers Non-Small-Cell Lung Cancer, Mitral Valve Regurgitation (Degenerative or Functional), Locally Advanced Solid Tumors.
Cedars-Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.